Healthcare stocks are higher with the NYSE Healthcare Sector
Index currently ahead over 0.8% while shares of healthcare
companies in the S&P 500 are up about 1.4% as a group.
In company news, Enzo Biochem Inc. (
) is down 7% at $2.11 a share following a move by Standard &
Poor's to drop the clinical research organization from the S&P
Smallcap 600 index next week.
ENZ will be replaced by Forest Oil (
), which is falling out of the S&P MidCap 400 Index after being
bumped by for-profit college chain Apollo Group (
). The changes will take place after the close of trading June
In other sector news,
(+) ORMP, Withdraws proposed public offering of 24 mln shares
filed with securities regulators on Jan. 11, citing market
(-) IDIX, FDA requests additional pre-clinical safety
information for its IDX209603 drug candidate, putting the start of
clinical testing is on hold until it can provide a satisfactory
response to the agency. IDIX recently submitted an Investigational
New Drug application for the prospective treatment for hepatitis
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.